《Table 1 Clinical characteristics》

《Table 1 Clinical characteristics》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录
Abbreviations:ALT，alanine aminotransferase；AST，aspartate aminotransferase；HBV，hepatitis B virus.Data are presented as mean（minimum-maximum）.

A total of 24 patients who underwent partial hepatectomy due to early-stage hepatocellular carcinoma with liver cirrhosis at The First Affiliated Hospital of Nanjing Medical University from January 2012 to December 2013 were involved in the study.Normal liver tissues were obtained as controls from 20 Chinese patients with benign disease，such as hemangioma.The clinical characteristics are summarized in Table 1.Informed consent for sample analysis was obtained from all patients before surgery，and the study was approved by the institutional ethics committee of The First Affiliated Hospital of Nanjing Medical University and performed according to the Declaration of Helsinki.

图表编号XD0010733600    严禁用于非法目的
绘制时间2018.04.01
作者Zhongming Tan、Qianghui Liu、Runqiu Jiang、Long Lv、Siamak S Shoto、Isabelle Maillet、Valerie Quesniaux、Junwei Tang、Wenjie Zhang、Beicheng Sun、Bernhard Ryffel
绘制单位Key Laboratory of Living Donor Liver Transplantation, Department of Liver Surgery, National Health and Family Planning Commission, The First Affiliated Hospital of Nanjing Medical University、Molecular Immunology and Embryology, UMR 7355, CNRS, University
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 1.Clinical Characteristics of CKD Participants[Median (IQR) ]》2019.03.01
  2. 《Table 1 Patient demographics and key clinical characteristics》2019.05.21
  3. 《Table 1 Patient demographics and key clinical characteristics》2019.05.21
  4. 《Table 1 Patient demographics and key clinical characteristics》2019.05.21
  5. 《Table 1 Clinical characteristics of the study subjects》2019.04.14
  6. 《Table 1 Clinical characteristics of 172 patients with SCC》2019.05.20
  7. 《Table 1.Patients'Baseline Clinical Characteristics[Case (%) ]》2019.01.01
  8. 《Table 1.Clinical characteristics of 148 patients with DLBCL》2019.02.20
  9. 《Table 1.Clinical characteristics of 148 patients with DLBCL》2019.02.20
  10. 《Table 1 Clinical characteristics of the study population》2019.06.01
  11. 《Table 1 Demographic, polysomnographic, and clinical characteristics of participants》2019.05.01
  12. 《Table 1 Demographic and clinical characteristics of the subjects》2019.05.01
  13. 《Table 1 Patients’clinical characteristics》2019.04.01
  14. 《Table 1 Demographics and clinical characteristics》2019.03.01
  15. 《Table 2 Clinical characteristics of study participants》2019.03.01
  16. 《Table 1 Patient demographic and clinical characteristics n (%)》2019.02.18
  17. 《Table 1 Demographic and clinical characteristics of the study population》2019.01.18
  18. 《Table 1 Clinical characteristics of the study subjects》2018.08.18
  19. 《Table 1 Demographic and clinical characteristics of all participants》2018.08.18
  20. 《Table 1Clinical characteristics of study participants.》2018.10.15

随机翻阅

《表1 两组下肢动脉血管病变情况比较[n(%)](n=66)》 《表9 不同加工强度样品的香韵风格评价结果》 《表1 池化方式对比表：基于深度学习的人脸识别方法》 《表8 劳动密集型产业的估计结果》 《表2 不同处理对水稻纹枯病的防效》 《表7 芯轴疲劳试验结果：基于疲劳寿命提升的橡胶球铰优化设计研究》 《表5 表面粗糙度的方差分析结果列表》 《表2 两组脱落癌细胞阳性率比较(n,%)》 《表3 青海湖自行车旅游者骑行偏好因子得分与检验》 《表1 签到数据结构一览表》